Literature DB >> 12908869

Particle size distribution and respiratory deposition estimates of beryllium aerosols in an extraction and processing plant.

D D Thorat1, T N Mahadevan, D K Ghosh.   

Abstract

The mass size distribution of beryllium aerosols generated in the various operational areas of a typical extraction and processing plant was studied using an eight-stage impactor sampler. The total concentration of beryllium in the plant was found to be well below the threshold limit value. The mean value of mass median aerodynamic diameter of beryllium particles observed for various operations ranged from 5.0-9.5 microm. The alveolar deposition for various operational areas was estimated to be 3-5% for nasal breathing and 9-13% for oral breathing based on the International Commission on Radiological Protection (ICRP) human respiratory tract model. Deposition during oral breathing was higher than during nasal breathing by approximately a factor of two to three. This study on exposure characterization was useful for reducing the respirable fraction of beryllium aerosol by optimizing the capture velocity and improving the quality of other control measures.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12908869     DOI: 10.1202/369.1

Source DB:  PubMed          Journal:  AIHA J (Fairfax, Va)        ISSN: 1542-8117


  2 in total

1.  A novel alternative to environmental monitoring to detect workers at risk for beryllium exposure-related health effects.

Authors:  Elizabeth Fireman; Yehuda Lerman; Moshe Stark; Asher Pardo; Yehuda Schwarz; Michael V Van Dyke; Jill Elliot; Briana Barkes; Lee Newman; Lisa Maier
Journal:  J Occup Environ Hyg       Date:  2014       Impact factor: 2.155

2.  Detection of vesicant-induced upper airway mucosa damage in the hamster cheek pouch model using optical coherence tomography.

Authors:  Marie J Hammer-Wilson; Vi Nguyen; Woong-Gyu Jung; Yehchen Ahn; Zhongping Chen; Petra Wilder-Smith
Journal:  J Biomed Opt       Date:  2010 Jan-Feb       Impact factor: 3.170

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.